North America Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Application, By Product (Instruments, Consumables, Services), By Technology, By Country and Growth Forecast, 2024 - 2031
Published Date : 27-Aug-2024 |
Pages: 128 |
Formats: PDF |
COVID-19 Impact on the North America Genomics In Cancer Care Market
Market Overview
The North America Genomics In Cancer Care Market would witness market growth of 15.0% CAGR during the forecast period (2024-2031).
The US market dominated the North America Genomics In Cancer Care Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $13,049.8 million by 2031. The Canada market is experiencing a CAGR of 17.5% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 16.5% during (2024 - 2031).
Genomics has revolutionized cancer care by offering insights into the genetic underpinnings of the disease, enabling more precise and personalized approaches to treatment. Genomics plays a crucial role in identifying rare genetic syndromes associated with increased cancer risk.
Additionally, by analyzing whole-genome or exome sequences, clinicians can identify mutations linked to rare inherited cancer syndromes, such as Li-Fraumeni syndrome or Lynch syndrome. Early identification of these syndromes allows for tailored screening and preventive measures for affected individuals and their families.
The growing incidence of cancer in Mexico drives the need for advanced diagnostic tools, including genomic technologies. These tools help in early cancer detection, identifying genetic mutations and biomarkers that can lead to more accurate and timely diagnoses. The increasing cancer burden encourages the expansion of genomic research initiatives in Mexico. Research institutions and universities may intensify their efforts to study cancer genomics, leading to the development of new diagnostic and therapeutic solutions and thus boosting the genomics market.
Free Valuable Insights: The Genomics In Cancer Care Market is Predict to reach USD 53.5 Billion by 2031, at a CAGR of 15.7%
Based on Application, the market is segmented into Diagnostics, Personalized Medicine, Drug Discovery & Development, and Research. Based on Product, the market is segmented into Instruments, Consumables, Services. Based on Technology, the market is segmented into PCR, Genome Sequencing, Microarrays, Nuclei Acid Extraction & Purification, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Agilent Technologies, Inc.
- F.Hoffmann-La Roche Ltd.
- Danaher Corporation (Beckman Coulter, Inc.)
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- GE HealthCare Technologies, Inc.
- Quest Diagnostics Incorporated
- Revvity, Inc.
- Eurofins Scientific SE
- Hologic, Inc.
North America Genomics In Cancer Care Market Report Segmentation
By Application
- Diagnostics
- Personalized Medicine
- Drug Discovery & Development
- Research
By Product
- Instruments
- Consumables
- Services
By Technology
- PCR
- Genome Sequencing
- Microarrays
- Nuclei Acid Extraction & Purification
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Genomics In Cancer Care Market, by Application
1.4.2 North America Genomics In Cancer Care Market, by Product
1.4.3 North America Genomics In Cancer Care Market, by Technology
1.4.4 North America Genomics In Cancer Care Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Mergers and Acquisitions: 2021, Jan – 2023, Jan) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. North America Genomics In Cancer Care Market by Application
5.1 North America Diagnostics Market by Country
5.2 North America Personalized Medicine Market by Country
5.3 North America Drug Discovery & Development Market by Country
5.4 North America Research Market by Country
Chapter 6. North America Genomics In Cancer Care Market by Product
6.1 North America Instruments Market by Country
6.2 North America Consumables Market by Country
6.3 North America Services Market by Country
Chapter 7. North America Genomics In Cancer Care Market by Technology
7.1 North America PCR Market by Country
7.2 North America Genome Sequencing Market by Country
7.3 North America Microarrays Market by Country
7.4 North America Nuclei Acid Extraction & Purification Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Genomics In Cancer Care Market by Country
8.1 US Genomics In Cancer Care Market
8.1.1 US Genomics In Cancer Care Market by Application
8.1.2 US Genomics In Cancer Care Market by Product
8.1.3 US Genomics In Cancer Care Market by Technology
8.2 Canada Genomics In Cancer Care Market
8.2.1 Canada Genomics In Cancer Care Market by Application
8.2.2 Canada Genomics In Cancer Care Market by Product
8.2.3 Canada Genomics In Cancer Care Market by Technology
8.3 Mexico Genomics In Cancer Care Market
8.3.1 Mexico Genomics In Cancer Care Market by Application
8.3.2 Mexico Genomics In Cancer Care Market by Product
8.3.3 Mexico Genomics In Cancer Care Market by Technology
8.4 Rest of North America Genomics In Cancer Care Market
8.4.1 Rest of North America Genomics In Cancer Care Market by Application
8.4.2 Rest of North America Genomics In Cancer Care Market by Product
8.4.3 Rest of North America Genomics In Cancer Care Market by Technology
Chapter 9. Company Profiles
9.1 Agilent Technologies, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.6 SWOT Analysis
9.3 Danaher Corporation (Beckman Coulter, Inc.)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.6 SWOT Analysis
9.4 Abbott Laboratories
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.5.6 SWOT Analysis
9.6 GE HealthCare Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.6 SWOT Analysis
9.7 Quest Diagnostics Incorporated
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.7.4 SWOT Analysis
9.8 Revvity, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Eurofins Scientific SE
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 SWOT Analysis
9.10. Hologic, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Genomics In Cancer Care Market, by Application
1.4.2 North America Genomics In Cancer Care Market, by Product
1.4.3 North America Genomics In Cancer Care Market, by Technology
1.4.4 North America Genomics In Cancer Care Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Mergers and Acquisitions: 2021, Jan – 2023, Jan) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. North America Genomics In Cancer Care Market by Application
5.1 North America Diagnostics Market by Country
5.2 North America Personalized Medicine Market by Country
5.3 North America Drug Discovery & Development Market by Country
5.4 North America Research Market by Country
Chapter 6. North America Genomics In Cancer Care Market by Product
6.1 North America Instruments Market by Country
6.2 North America Consumables Market by Country
6.3 North America Services Market by Country
Chapter 7. North America Genomics In Cancer Care Market by Technology
7.1 North America PCR Market by Country
7.2 North America Genome Sequencing Market by Country
7.3 North America Microarrays Market by Country
7.4 North America Nuclei Acid Extraction & Purification Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Genomics In Cancer Care Market by Country
8.1 US Genomics In Cancer Care Market
8.1.1 US Genomics In Cancer Care Market by Application
8.1.2 US Genomics In Cancer Care Market by Product
8.1.3 US Genomics In Cancer Care Market by Technology
8.2 Canada Genomics In Cancer Care Market
8.2.1 Canada Genomics In Cancer Care Market by Application
8.2.2 Canada Genomics In Cancer Care Market by Product
8.2.3 Canada Genomics In Cancer Care Market by Technology
8.3 Mexico Genomics In Cancer Care Market
8.3.1 Mexico Genomics In Cancer Care Market by Application
8.3.2 Mexico Genomics In Cancer Care Market by Product
8.3.3 Mexico Genomics In Cancer Care Market by Technology
8.4 Rest of North America Genomics In Cancer Care Market
8.4.1 Rest of North America Genomics In Cancer Care Market by Application
8.4.2 Rest of North America Genomics In Cancer Care Market by Product
8.4.3 Rest of North America Genomics In Cancer Care Market by Technology
Chapter 9. Company Profiles
9.1 Agilent Technologies, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.6 SWOT Analysis
9.3 Danaher Corporation (Beckman Coulter, Inc.)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.6 SWOT Analysis
9.4 Abbott Laboratories
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.5.6 SWOT Analysis
9.6 GE HealthCare Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.6 SWOT Analysis
9.7 Quest Diagnostics Incorporated
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.7.4 SWOT Analysis
9.8 Revvity, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Eurofins Scientific SE
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 SWOT Analysis
9.10. Hologic, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis
List of Tables
TABLE 1 North America Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 2 North America Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Genomics In Cancer Care Market
TABLE 4 Product Launches And Product Expansions– Genomics In Cancer Care Market
TABLE 5 Acquisition and Mergers– Genomics In Cancer Care Market
TABLE 6 North America Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 7 North America Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 8 North America Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 9 North America Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 10 North America Personalized Medicine Market by Country, 2020 - 2023, USD Million
TABLE 11 North America Personalized Medicine Market by Country, 2024 - 2031, USD Million
TABLE 12 North America Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 13 North America Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 14 North America Research Market by Country, 2020 - 2023, USD Million
TABLE 15 North America Research Market by Country, 2024 - 2031, USD Million
TABLE 16 North America Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 17 North America Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 18 North America Instruments Market by Country, 2020 - 2023, USD Million
TABLE 19 North America Instruments Market by Country, 2024 - 2031, USD Million
TABLE 20 North America Consumables Market by Country, 2020 - 2023, USD Million
TABLE 21 North America Consumables Market by Country, 2024 - 2031, USD Million
TABLE 22 North America Services Market by Country, 2020 - 2023, USD Million
TABLE 23 North America Services Market by Country, 2024 - 2031, USD Million
TABLE 24 North America Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 25 North America Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 26 North America PCR Market by Country, 2020 - 2023, USD Million
TABLE 27 North America PCR Market by Country, 2024 - 2031, USD Million
TABLE 28 North America Genome Sequencing Market by Country, 2020 - 2023, USD Million
TABLE 29 North America Genome Sequencing Market by Country, 2024 - 2031, USD Million
TABLE 30 North America Microarrays Market by Country, 2020 - 2023, USD Million
TABLE 31 North America Microarrays Market by Country, 2024 - 2031, USD Million
TABLE 32 North America Nuclei Acid Extraction & Purification Market by Country, 2020 - 2023, USD Million
TABLE 33 North America Nuclei Acid Extraction & Purification Market by Country, 2024 - 2031, USD Million
TABLE 34 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 35 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 36 North America Genomics In Cancer Care Market by Country, 2020 - 2023, USD Million
TABLE 37 North America Genomics In Cancer Care Market by Country, 2024 - 2031, USD Million
TABLE 38 US Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 39 US Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 40 US Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 41 US Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 42 US Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 43 US Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 44 US Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 45 US Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 46 Canada Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 47 Canada Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 48 Canada Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 49 Canada Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 50 Canada Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 51 Canada Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 52 Canada Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 53 Canada Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 54 Mexico Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 55 Mexico Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 56 Mexico Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 57 Mexico Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 58 Mexico Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 59 Mexico Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 60 Mexico Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 61 Mexico Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 62 Rest of North America Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 63 Rest of North America Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 64 Rest of North America Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 65 Rest of North America Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 66 Rest of North America Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 67 Rest of North America Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 68 Rest of North America Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 69 Rest of North America Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 70 key Information – Agilent Technologies, Inc.
TABLE 71 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 72 Key Information – Danaher Corporation
TABLE 73 Key Information – Abbott Laboratories
TABLE 74 Key Information – Bio-Rad Laboratories, Inc.
TABLE 75 Key Information – GE HealthCare Technologies, Inc.
TABLE 76 Key information – Quest Diagnostics Incorporated
TABLE 77 Key Information – Revvity, Inc.
TABLE 78 Key Information – Eurofins Scientific SE
TABLE 79 Key Information – Hologic, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Genomics In Cancer Care Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Genomics In Cancer Care Market
FIG 4 KBV Cardinal Matrix
FIG 5 Market Share Analysis, 2023
FIG 6 Key Leading Strategies: Percentage Distribution (2020-2024)
FIG 7 Key Strategic Move: (Mergers and Acquisitions : 2021, Jan – 2023, Jan) Leading Players
FIG 8 Porter’s Five Forces Analysis – Genomics In Cancer Care Market
FIG 9 North America Genomics In Cancer Care Market share by Application, 2023
FIG 10 North America Genomics In Cancer Care Market share by Application, 2031
FIG 11 North America Genomics In Cancer Care Market by Application, 2020 - 2031, USD Million
FIG 12 North America Genomics In Cancer Care Market share by Product, 2023
FIG 13 North America Genomics In Cancer Care Market share by Product, 2031
FIG 14 North America Genomics In Cancer Care Market by Product, 2020 - 2031, USD Million
FIG 15 North America Genomics In Cancer Care Market share by Technology, 2023
FIG 16 North America Genomics In Cancer Care Market share by Technology, 2031
FIG 17 North America Genomics In Cancer Care Market by Technology, 2020 - 2031, USD Million
FIG 18 North America Genomics In Cancer Care Market share by Country, 2023
FIG 19 North America Genomics In Cancer Care Market share by Country, 2031
FIG 20 North America Genomics In Cancer Care Market by Country, 2020 - 2031, USD Million
FIG 21 Swot Analysis: Agilent Technologies, Inc.
FIG 22 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 23 SWOT Analysis: Danaher Corporation
FIG 24 SWOT Analysis: Abbott Laboratories
FIG 25 SWOT Analysis: Bio-Rad Laboratories, Inc.
FIG 26 SWOT Analysis: GE HealthCare Technologies, Inc.
FIG 27 SWOT Analysis: Quest Diagnostics Incorporated
FIG 28 Swot Analysis: Revvity, Inc.
FIG 29 SWOT Analysis: Eurofins Scientific SE
FIG 30 Swot Analysis: Hologic, Inc.
TABLE 2 North America Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Genomics In Cancer Care Market
TABLE 4 Product Launches And Product Expansions– Genomics In Cancer Care Market
TABLE 5 Acquisition and Mergers– Genomics In Cancer Care Market
TABLE 6 North America Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 7 North America Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 8 North America Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 9 North America Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 10 North America Personalized Medicine Market by Country, 2020 - 2023, USD Million
TABLE 11 North America Personalized Medicine Market by Country, 2024 - 2031, USD Million
TABLE 12 North America Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 13 North America Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 14 North America Research Market by Country, 2020 - 2023, USD Million
TABLE 15 North America Research Market by Country, 2024 - 2031, USD Million
TABLE 16 North America Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 17 North America Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 18 North America Instruments Market by Country, 2020 - 2023, USD Million
TABLE 19 North America Instruments Market by Country, 2024 - 2031, USD Million
TABLE 20 North America Consumables Market by Country, 2020 - 2023, USD Million
TABLE 21 North America Consumables Market by Country, 2024 - 2031, USD Million
TABLE 22 North America Services Market by Country, 2020 - 2023, USD Million
TABLE 23 North America Services Market by Country, 2024 - 2031, USD Million
TABLE 24 North America Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 25 North America Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 26 North America PCR Market by Country, 2020 - 2023, USD Million
TABLE 27 North America PCR Market by Country, 2024 - 2031, USD Million
TABLE 28 North America Genome Sequencing Market by Country, 2020 - 2023, USD Million
TABLE 29 North America Genome Sequencing Market by Country, 2024 - 2031, USD Million
TABLE 30 North America Microarrays Market by Country, 2020 - 2023, USD Million
TABLE 31 North America Microarrays Market by Country, 2024 - 2031, USD Million
TABLE 32 North America Nuclei Acid Extraction & Purification Market by Country, 2020 - 2023, USD Million
TABLE 33 North America Nuclei Acid Extraction & Purification Market by Country, 2024 - 2031, USD Million
TABLE 34 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 35 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 36 North America Genomics In Cancer Care Market by Country, 2020 - 2023, USD Million
TABLE 37 North America Genomics In Cancer Care Market by Country, 2024 - 2031, USD Million
TABLE 38 US Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 39 US Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 40 US Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 41 US Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 42 US Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 43 US Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 44 US Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 45 US Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 46 Canada Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 47 Canada Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 48 Canada Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 49 Canada Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 50 Canada Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 51 Canada Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 52 Canada Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 53 Canada Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 54 Mexico Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 55 Mexico Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 56 Mexico Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 57 Mexico Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 58 Mexico Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 59 Mexico Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 60 Mexico Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 61 Mexico Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 62 Rest of North America Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 63 Rest of North America Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 64 Rest of North America Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 65 Rest of North America Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 66 Rest of North America Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 67 Rest of North America Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 68 Rest of North America Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 69 Rest of North America Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 70 key Information – Agilent Technologies, Inc.
TABLE 71 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 72 Key Information – Danaher Corporation
TABLE 73 Key Information – Abbott Laboratories
TABLE 74 Key Information – Bio-Rad Laboratories, Inc.
TABLE 75 Key Information – GE HealthCare Technologies, Inc.
TABLE 76 Key information – Quest Diagnostics Incorporated
TABLE 77 Key Information – Revvity, Inc.
TABLE 78 Key Information – Eurofins Scientific SE
TABLE 79 Key Information – Hologic, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Genomics In Cancer Care Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Genomics In Cancer Care Market
FIG 4 KBV Cardinal Matrix
FIG 5 Market Share Analysis, 2023
FIG 6 Key Leading Strategies: Percentage Distribution (2020-2024)
FIG 7 Key Strategic Move: (Mergers and Acquisitions : 2021, Jan – 2023, Jan) Leading Players
FIG 8 Porter’s Five Forces Analysis – Genomics In Cancer Care Market
FIG 9 North America Genomics In Cancer Care Market share by Application, 2023
FIG 10 North America Genomics In Cancer Care Market share by Application, 2031
FIG 11 North America Genomics In Cancer Care Market by Application, 2020 - 2031, USD Million
FIG 12 North America Genomics In Cancer Care Market share by Product, 2023
FIG 13 North America Genomics In Cancer Care Market share by Product, 2031
FIG 14 North America Genomics In Cancer Care Market by Product, 2020 - 2031, USD Million
FIG 15 North America Genomics In Cancer Care Market share by Technology, 2023
FIG 16 North America Genomics In Cancer Care Market share by Technology, 2031
FIG 17 North America Genomics In Cancer Care Market by Technology, 2020 - 2031, USD Million
FIG 18 North America Genomics In Cancer Care Market share by Country, 2023
FIG 19 North America Genomics In Cancer Care Market share by Country, 2031
FIG 20 North America Genomics In Cancer Care Market by Country, 2020 - 2031, USD Million
FIG 21 Swot Analysis: Agilent Technologies, Inc.
FIG 22 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 23 SWOT Analysis: Danaher Corporation
FIG 24 SWOT Analysis: Abbott Laboratories
FIG 25 SWOT Analysis: Bio-Rad Laboratories, Inc.
FIG 26 SWOT Analysis: GE HealthCare Technologies, Inc.
FIG 27 SWOT Analysis: Quest Diagnostics Incorporated
FIG 28 Swot Analysis: Revvity, Inc.
FIG 29 SWOT Analysis: Eurofins Scientific SE
FIG 30 Swot Analysis: Hologic, Inc.